American Association for Cancer Research

Skip to Main Content

Table 1

Patient characteristics

Age	Median 51.6 years (range, 40.8–64.5 years)
ER/PR^a status
Positive/positive	4
Negative/positive	1
Positive/negative	1
Negative/negative	11
Unknown	1
Tumor grade
Grade 2/3	1
Grade 3/3	14
Not stated	3
Her-2/Neu
Positive	5
Weakly positive	1
Negative	11
Unknown	1
LVI
Positive	9
Negative	9
Stage distributions
T3	3
T4	13
T4 (recurrent)	2
Metastasis	7
No metastases	11

Age	Median 51.6 years (range, 40.8–64.5 years)
ER/PR^a status
Positive/positive	4
Negative/positive	1
Positive/negative	1
Negative/negative	11
Unknown	1
Tumor grade
Grade 2/3	1
Grade 3/3	14
Not stated	3
Her-2/Neu
Positive	5
Weakly positive	1
Negative	11
Unknown	1
LVI
Positive	9
Negative	9
Stage distributions
T3	3
T4	13
T4 (recurrent)	2
Metastasis	7
No metastases	11

^a

ER, estrogen receptor; PR, progesterone receptor; LVI, lymphovascular invasion.